Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.04. | ACRUX LIMITED: Details of Share Registry address | 1 | ASX | ||
04.04. | ACRUX LIMITED: Appendix 3Y Dobinson | 2 | ASX | ||
04.04. | ACRUX LIMITED: Application for quotation of securities - ACR | 3 | ASX | ||
03.04. | ACRUX LIMITED: Acrux receives $1.73m advance on FY25 R&D Tax Incentive | 1 | ASX | ||
ACRUX Aktie jetzt für 0€ handeln | |||||
05.03. | ACRUX LIMITED: Attaching Options final application date 31 March 2025 | - | ASX | ||
04.03. | ACRUX LIMITED: Notification of cessation of securities - ACR | - | ASX | ||
03.03. | ACRUX LIMITED: Cleansing Notice | 1 | ASX | ||
03.03. | ACRUX LIMITED: Application for quotation of securities - ACR | - | ASX | ||
02.03. | ACRUX LIMITED: Appendix 3Y Dobinson | - | ASX | ||
25.02. | ACRUX LIMITED: Investor Presentation February 2025 | - | ASX | ||
25.02. | ACRUX LIMITED: Investor Webinar Announcement | - | ASX | ||
25.02. | ACRUX LIMITED: Appendix 4D and December 2024 Half Year Accounts | - | ASX | ||
19.02. | ACRUX LIMITED: Top20 quoted option holders and distribution schedule | - | ASX | ||
19.02. | ACRUX LIMITED: Appendix 3Y Kotsanis | 1 | ASX | ||
19.02. | ACRUX LIMITED: Appendix 3Y Oldham | 1 | ASX | ||
19.02. | ACRUX LIMITED: Appendix 3Y Brooke | 1 | ASX | ||
19.02. | ACRUX LIMITED: Appendix 3Y Brumley | 2 | ASX | ||
19.02. | ACRUX LIMITED: Application for quotation of securities - ACR | 1 | ASX | ||
18.02. | ACRUX LIMITED: Issue of Attaching Options initiated, extended Closing Date | - | ASX | ||
16.02. | ACRUX LIMITED: Notification regarding unquoted securities - ACR | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TILRAY BRANDS | 0,395 | -0,45 % | Tilray Brands, Inc.: Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders | NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at... ► Artikel lesen | |
METSERA | 19,510 | 0,00 % | Why did Lilly data for oral GLP-1 boost Structure and Metsera? | ||
HARROW | 23,240 | -3,13 % | Harrow Health Aktie: Ein dunkler Schatten fällt! | Das Pharmaunternehmen verbucht starke Quartalszahlen mit 66,83 Millionen Dollar Umsatz, während die Aktie dennoch einen Abwärtstrend von 5,75% fortsetzt. Der Aktienkurs von Harrow Health ist am Freitag... ► Artikel lesen | |
UNIVERSE PHARMACEUTICALS | 4,250 | 0,00 % | Universe Pharmaceuticals Plans To Effect Share Consolidation | BEIJING (dpa-AFX) - Universe Pharmaceuticals (UPC) said it plans to effect a share consolidation of 40 ordinary shares with par value of $0.28125 per share each in the companys issued
and... ► Artikel lesen | |
PFIZER | 19,202 | -1,40 % | DAX nähert sich 21.000 Punkten - LVMH, Stellantis, Webull, Pfizer, Palantir, Meta, Intel, Nvidia, BP | Der DAX ist stark in die neue Woche gestartet. Gestern schloss er 2,85 Prozent höher bei 20.954 Punkten. Die Märkte hoffen auf eine Deeskalation im Zollstreit. Auch die Vorgaben aus Übersee sind überwiegend... ► Artikel lesen | |
ZHENGYE BIOTECHNOLOGY | 7,920 | 0,00 % | Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering | Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development... ► Artikel lesen | |
ASTRIA THERAPEUTICS | 4,110 | +1,73 % | Astria Therapeutics, Inc.: Astria Therapeutics beginnt Phase-3-Zulassungsstudie ALPHA-ORBIT zu Navenibart bei hereditärem Angioödem | -- Studie zum Nachweis der Wirksamkeit und Sicherheit der Verabreichung alle 3 und alle 6 Monate in einem 6-monatigen Behandlungszeitraum --
Astria Therapeutics, Inc. (Nasdaq: ATXS), ein biopharmazeutisches... ► Artikel lesen | |
ETON PHARMACEUTICALS | 14,260 | -0,56 % | Eton Pharmaceuticals Out-Licenses International Rights to Increlex | DEER PARK, Ill., April 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton" or the "Company") (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
SUNSHINE BIOPHARMA | 1,290 | 0,00 % | Sunshine Biopharma Inc.: Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas... ► Artikel lesen | |
AQUESTIVE THERAPEUTICS | 2,585 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Anaphylm (epinephrine) Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting scheduled for fourth quarter 2024Libervant® (diazepam) Buccal... ► Artikel lesen | |
CHINA SXT PHARMACEUTICALS | 1,010 | 0,00 % | China SXT Pharmaceuticals Stock Surges 90% | ||
SHINECO | 0,509 | 0,00 % | Shineco, Inc.: Shineco Announces Acquisition of Medical Device Company | The Acquisition is Expected to Create Immediate Synergies with the Company's Existing Medical Device Business BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"... ► Artikel lesen | |
ABBOTT LABORATORIES | 112,58 | -2,27 % | Ihre wichtigsten Termine: Spannende Updates von: Nestle, Abbott Laboratories, Heineken & Lindt & Sprüngli | © Foto: Jean-Christophe Bott - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
MILESTONE PHARMACEUTICALS | 1,015 | 0,00 % | Milestone Pharmaceuticals Inc.: FDA Issues Complete Response Letter for Etripamil for PSVT | CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025... ► Artikel lesen | |
OMNIAB | 1,825 | +1,96 % | OmniAb expands board with two new directors |